Iowa City, IA, United States of America

Yong You

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • Coralville, IA (US) (2011)
  • Iowa City, IA (US) (2015 - 2018)

Company Filing History:


Years Active: 2011-2018

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Yong You: Innovator in Antisense Oligonucleotide Modifications

Introduction

Yong You is a prominent inventor based in Iowa City, IA (US), known for his contributions to the field of molecular biology. He holds a total of 4 patents, focusing on advancements in antisense oligonucleotides. His work aims to enhance the stability and efficacy of these compounds, which are crucial in various therapeutic applications.

Latest Patents

One of Yong You's latest patents involves modifications for antisense compounds. This invention pertains to modifications for antisense oligonucleotides, wherein the modifications are used to improve stability and provide protection from nuclease degradation. These modifications can also be incorporated into double-stranded nucleic acids, such as synthetic siRNAs and miRNAs. This innovative approach has the potential to significantly impact the development of RNA-based therapies.

Career Highlights

Yong You is currently associated with Integrated DNA Technologies, Inc., where he continues to push the boundaries of genetic research. His work has been instrumental in advancing the understanding and application of antisense technology in therapeutic contexts.

Collaborations

Yong has collaborated with notable colleagues in the field, including Mark Aaron Behlke and Richard Owczarzy. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Yong You's contributions to the field of antisense oligonucleotides exemplify the importance of innovation in biotechnology. His patents and ongoing research continue to pave the way for advancements in genetic therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…